ROSSARI452.00

Rossari Biotech Limited

· Chemicals
₹ CrorePeersNOCILHSCLNAVINFLUORDDEVPLSTIKCHEMPLASTSTATACHEMAARTIINDJGCHEMMcap ₹2,503 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)83.7999.7292.0892.08
Receivable Days (DSO)84.7783.2584.9084.90
Payable Days (DPO)65.0280.4273.6255.73
Cash Conversion Cycle (days)103.54102.55103.36121.25
Working Capital Turnover4.374.125.376.93
Asset Turnover1.161.101.051.05
Cash Conversion (CFO/Net Income)0.331.010.440.44
CFO/EBITDA0.170.520.230.23
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.